James M. Beck

Reed Smith LLP

Legal Influencer

Q3 | 2018

Legal Influencers

Lexology’s Legal Influencers programme recognises firms and authors that provide excellent content within a work area and region. Find out more

  • Q3 | 2018 in Healthcare and life sciences - US

Articles

Results 1 to 5 of 691
Most popular |Most recent


Making It Snappy in New York

USA - May 21 2020 There’s a reason plaintiffs hate removal before service - “snap removal.” It has the potential to wreak havoc on their mass tort business models...

FDA Nonacquiescence Strategy Fails In Evergreening Case

USA - May 18 2020 One of the advantages that the FDA (and other government Agencies) have over other litigants is that it gets to ignore court decisions it doesn’t...

Quasi-Guest Post - Plaintiffs’ Beast of Burden: Adverse Event Reports Precede Causation

USA - May 12 2020 We’re calling this a “quasi” guest post because the author, Reed Smith‘s Dean Balaes, is actually trying out to join our blogging team. This is his...

On Newly Acquired Information

USA - May 11 2020 We’ve noticed quite a few prescription drug preemption decisions lately involving “newly acquired information.” That’s because the Supreme Court...

Post-Albrecht Preemption Persistently Pummels Pradaxa Plaintiffs

USA - May 6 2020 Not long ago, in our “Post-Albrecht Preemption Pummels Pradaxa Plaintiffs” post we discussed several recent favorable preemption decisions in product...